Carboplatin Injection, Solution
Product Images NDC 61703-339

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Carboplatin (NDC 61703-339). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Carboplatin 01)

Chemical structure of carboplatin, showing the platinum atom centrally bonded to two ammine groups and a bidentate cyclobutane dicarboxylate ligand.*

FDA Label Image

Logo (Carboplatin 01a)

FDA Label Image

Logo (Carboplatin 02)

FDA Label Image

Logo (Carboplatin 02a)

FDA Label Image

Principal Display Panel (5 mL Vial Label)

Label for Carboplatin Injection 50 mg/5 mL (10 mg/mL) intravenous solution in a 5 mL multi-dose vial. The label states it is a sterile, prescription-only, cytotoxic agent. It lists active ingredient strength and volume, contains warnings about preservatives, and storage instructions. The label includes the NDC 61703-339-18 and identifies Hospira, Inc. as the distributor.*

FDA Label Image

Principal Display Panel (5 mL Vial Carton)

Carboplatin Injection 50 mg/5 mL (10 mg/mL) sterile solution for intravenous use, multi-dose vial, packaged by Hospira, Inc. The label includes storage instructions, highlights that the product is a cytotoxic agent, and states it is made in Germany. The NDC number 61703-339 is visible along with warnings and handling instructions on the carton.*

FDA Label Image

Principal Display Panel (15 mL Vial Label)

Carboplatin Injection label showing 150 mg per 15 mL (10 mg/mL) solution in a 15 mL multi-dose vial for intravenous use. The label indicates it is a cytotoxic agent, sterile, and for Rx only, distributed by Hospira, Inc.*

FDA Label Image

Principal Display Panel (15 mL Vial Carton)

Packaging label for Carboplatin Injection 150 mg/15 mL (10 mg/mL) solution for intravenous use by Hospira, Inc. The label indicates a multi-dose vial and includes warnings that it is a cytotoxic agent. Storage instructions and a barcode are visible, along with mention that the product is made in Germany and distributed from Lake Forest, Illinois.*

FDA Label Image

Principal Display Panel (45 mL Vial Label)

Carboplatin Injection 450 mg/45 mL (10 mg/mL) intravenous solution in a 45 mL multi-dose vial. The label indicates the product is sterile and for intravenous use only, marked as a cytotoxic agent. It includes storage instructions and warnings. Distributed by Hospira, Inc.*

FDA Label Image

Principal Display Panel (45 mL Vial Carton)

Carboplatin Injection 450 mg/45 mL (10 mg/mL) multi-dose vial packaging label by Hospira, Inc. The label includes dosing information, storage instructions, and highlights that the product is a cytotoxic agent for intravenous use, sterile, and Rx only. The label also indicates the product is distributed by Hospira, Inc., made in Germany, and the vial contains no preservatives.*

FDA Label Image

Principal Display Panel (60 mL Vial Label)

Carboplatin Injection label showing 600 mg per 60 mL (10 mg/mL) solution in a 60 mL multi-dose vial. The label indicates intravenous use and highlights the product as a cytotoxic agent. It includes manufacturer details for Hospira, Inc., with NDC 61703-339-56, and safety instructions such as storage temperature and protection from light.*

FDA Label Image

Principal Display Panel (60 mL Vial Carton)

Carboplatin Injection 600 mg/60 mL (10 mg/mL) multi-dose vial label by Hospira, Inc. The label indicates the vial contains 600 mg Carboplatin and water for injection with no preservatives. Storage instructions include keeping at 25°C with permitted excursions and protecting from light. The label bears a red warning strip stating 'Cytotoxic Agent' and notes the product is for intravenous use. The NDC shown is 61703-339-56; distributed by Hospira, Inc., made in Germany.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.